Joint Programme by the DFG and the BMBF
The DFG and the German Federal Ministry of Education and Research (BMBF) are continuing their joint programme on clinical trials. Proposals are accepted and reviewed within the framework of two complementary, coordinated funding measures in a two-stage process according to uniform, internationally recognised standards.
Funding by the BMBF focuses on interventional trials on pharmacological therapeutic measures, meta-analyses and reviews of clinical trials. The DFG primarily funds interventional clinical trials on non-pharmacological therapeutic procedures, in addition to prognostic trials and controlled trials on secondary prevention, provided that an intervention is planned for each, and diagnostic trials in phases II-III. Gender and age group-specific aspects should be taken into account in all trials. Applicants should have completed appropriate preliminary work relevant to the clinical trial. Projects must follow the rules of good clinical practice (ICH GCP).